Skip to content

AMN Healthcare AMN Forfeited (in dollars per share)

Forfeited (in dollars per share) at other companies

DJT
Trump Media & Technology GroupDJT
$0.00
Accenture logo
AccentureACN
$345.82+18.5%
Corvex
 logo
Corvex MOVE
$6.47
Sysco logo
SyscoSYY
$78.61+1.2%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$5.42+274%
CSX logo
CSXCSX
$34.38+40.4%

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.23B+47.0%
Enterprise value$1.41B-13.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.

The official record: AMN Healthcare’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's forfeited (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's forfeited (in dollars per share)?
AMN Healthcare (AMN) reported forfeited (in dollars per share) of $63.73 in Q4 2025.
How has AMN Healthcare's forfeited (in dollars per share) changed year-over-year?
AMN Healthcare's forfeited (in dollars per share) decreased by 29.7% year-over-year, from $90.66 to $63.73.
What does forfeited (in dollars per share) mean?
This is the weighted average grant date fair value of non-option equity awards that were forfeited during the reporting period. It provides context on the potential compensation expense that was reversed or avoided due to the cancellation of these unvested equity grants.